Prognostic Criteria for Squamous Cell Cancer of the Skin

Journal of Surgical Research

Volumn 159, Issue 1, 2010, Pages 509-516

  Jensen, Vanessa ^a   Prasad, Anil R ^a,b   Smith, Aaron ^a   Raju, Menaka ^a   Wendel, Christopher S ^a   Schmelz, Monika ^a   Leyva, William ^a,b   Warneke, James ^a   Krouse, Robert S ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

carcinoma; cutaneous; histopathology; immunochemistry; prognosis; squamous

Indexed keywords

CYCLIN D1; KI 67 ANTIGEN; PROTEIN P53; UVOMORULIN;

AGED; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISTANT METASTASIS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RECURRENCE RISK; SKIN CARCINOMA; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; SURVIVAL TIME;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; HUMANS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SKIN; SKIN NEOPLASMS;

EID: 76749101275     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.12.008     Document Type: Article

References (40)

1. American Cancer Society. Cancer facts and figures 2002 (2002), American Cancer Society Inc, Atlanta
2. Abdulla F., Feldman S., and Wiliford P. Tanning and skin cancer. Pediatr Dermatol 22 (2005) 501
3. Kwa R.E., Campana K., and Moy R.L. Biology of cutaneous squamous cell carcinoma. J Am Acad Dermatol 26 (1992) 1
4. Moller R., Reymann F., and Hou-Jensen K. Metastases in dermatological patients with squamous cell carcinoma. Arch Dermatol 115 (1979) 703
5. Rowe D.C., and Carroll R.J. Day CL Jr. Prognostic factors for local recurrence metastasis and survival rates in squamous cell carcinoma of the skin, ear and lip: Implications for treatment modality selection. J Am Acad Dermatol 26 (1992) 976
6. Lewis K.G., and Weinstock M.A. Nonmelanoma skin cancer mortality (1988-2000): The Rhode Island follow-back study. Arch Dermatol 140 (2004) 837
7. Batinac T., Zomolo G., Jonic N., et al. P53 protein expression and cell proliferation in non-neoplastic and neoplastic proliferative skin diseases. Tumori 90 (2004) 120
8. Chiles M.C., Ai L., Zuo C., et al. E-cadherin promoter hypermethylation in preneoplastic and neoplastic skin lesions. Mod Pathol 16 (2003) 1014
9. Bode A.M., and Dong Z. Posttranslational modification of p53 in tumorigenesis. Nat Rev Cancer 4 (2004) 793
10. Nelson M.A., Einspahr J.G., Alberts D.S., et al. Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. Cancer Lett 85 (1994) 23
11. Skalova A., and Michal M. Patterns of cell proliferation in actinic keratoacanthomas and squamous cell carcinomas of the skin: Immunohistochemical study using the MIB 1 antibody in formalin fixed paraffin sections. Am J Dermatopathol 17 (1995) 332
12. Burnworth B., Popp S., Stark H.-J., et al. Gain of 11q/cyclin D1 overexpression is an essential early step in skin cancer development and causes abnormal tissue organization and differentiation. Oncogene 25 (2006) 4399
13. Miller S.J., Alam M., Andersen J., et al. Basal cell and squamous cell skin cancers. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology, version 1.2007. Jenkintown: National Comprehensive Cancer Network (2007)
14. Selim A., Berlowitz D., and Fincke G. Risk-adjusted mortality rates as a potential outcome indicator for outpatient quality assessments. Med Care 40 (2002) 237
15. Moore B., Weber R.S., Prieto V., et al. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 115 (2006) 1561
16. Cherpelis B., and Marcusen C. Lang PG. Prognostic factors for metastasis in squamous cell carcinoma of the skin. Dermatol Surg 28 (2002) 268
17. Johnson T.M., Rowe D.E., Nelson B.R., et al. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 6 (1992) 467
18. Alam M., and Ratner D. Cutaneous squamous cell carcinoma. N Engl J Med 344 (2001) 975
19. Clayman G.L., Lee J.L., Holsinger C., et al. Mortality risk from squamous cell skin cancer. J Clin Oncol 22 (2005) 759
20. Khanna M., Fortier-Riberdy G., Dinehart S.M., et al. Histopathologic evaluation of cutaneous squamous cell carcinoma: Results of a survey among dermatopathologists. J Am Acad Dermatol 48 (2003) 721
21. Lyakhovitsky A., Barzilai A., Fogel M., et al. Expression of E-cadherin and beta catenin in cutaneous squamous cell carcinoma and its precursors. Am J Dermatopathol 26 (2004) 372
22. Yeh K.T., Shih M.C., Lin T.H., et al. The correlation between CpG methylation on promoter and protein expression of E- cadherin in oral squamous cell carcinoma. Anticancer Res 22 (2002) 3971
23. Brown D.C., and Gulten K.C. ki-67 protein: The immaculate deception?. Histopathology 40 (2002) 2
24. Shimikzu T., Muko M., Murakami T., et al. Overexpression of p53 protein associated with proliferative activity as evaluated by ki-67 immunostaining in well-differentiated Squamous Cell Carcinoma of the skin. Dermatology 193 (1977) 224
25. Mansoor A., Mekee P., Simpson J., et al. Prognostic significance of Ki-67 and p53 immuno reactivity in Cutaneous Squamous Cell Carcinoma. Ann J Dermatopatholgy 18 (1996) 351
26. Pierceall W.E., Mukhopadhyay T., Goldberg L.H., et al. Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas. Mol Carcinog 4 (1991) 445
27. Kubo Y., Urano Y., Yoshimoto K., et al. p53 gene mutations in human skin cancers and precancerous lesions: Comparison with immunohistochemical analysis. J Invest Dermatol 102 (1994) 440
28. Campbell C., Quinn A.G., Ro Y.S., et al. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. J Invest Dermatol 100 (1993) 746
29. Serewko M., Popa C., Dahler A., et al. Alterations in gene expression and activity during Squamous Cell Carcinoma development. Cancer Research 62 (2002) 3759
30. Bito T., Ueda M., Ahmed N.U., et al. Cyclin D and retinoblastoma gene product expression in actinic keratosis and cutaneous squamous cell carcinoma in relation to p53 expression. J Cutan Pathol 22 (1995) 427
31. Mullen J.T., Feng L., Xing Y., et al. Invasive squamous cell carcinoma of the skin: Defining a high-risk group. Ann Surg Oncol 13 (2006) 902
32. Renzi C., Caggiati A., Mannooranparampil T.J., et al. Sentinel lymph node biopsy for high risk cutaneous squamous cell carcinoma: Case series and review of the literature. Eur J Surg Oncol 33 (2007) 364
33. Ross A.S., and Schmults C.D. Sentinel lymph node biopsy in cutaneous squamous cell carcinoma: A systematic review of the English literature. Dermatol Surg 32 (2006) 1309
34. Harwood C.A., Proby C.M., McGregor J.M., et al. Clinicopathologic features of skin cancer in organ transplant recipients: A retrospective case-control series. J Am Acad Dermatol 54 (2006) 290
35. Nguyen P., Vin-Christian K., Ming M.E., et al. Aggressive squamous cell carcinoma in persons infected with human immunodeficiency virus. Arch Dermatol 138 (2002) 758
36. Euvrard S., Kanitakis J., Pouteil-Noble C., et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 33 (1995) 222
37. Bouwes Bavinck J.N., Hardie D.R., Green A., et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: A follow-up study. Transplantation 61 (1996) 715
38. Jensen P., Moller B., and Hansen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 42 (2000) 307
39. Lindelof B., Jarnvik J., Ternesten-Brakel A., et al. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: A study of the Swedish cohort. Acta Derm Venereol 88 (2006) 219
40. Charles A.J., Otley C.C., and Pond G.R. Prognostic factors for life expectancy in nonagenarians with nonmelanoma skin cancer: Implications for selecting surgical candidates. J Am Acad Dermatol 47 (2002) 419